On August 6, SHIN NIPPON BIOMEDICAL LABORATORIES will be reporting earnings Q1. Wall Street analysts expect SHIN NIPPON BIOMEDICAL LABORATORIES will report earnings per share of ¥24.97.

James Carthew, head of investment companies at Quoteddata asked whether the share buyback suggestion was “too little, too late” for Shin Nippon. After a year of abysmal performance ...

Shin Nippon Biomedical Laboratories, Ltd. (JP:2395) has released an update. Shin Nippon Biomedical Laboratories reported a 5.3% increase in revenue for the six months ending September 2024 ...

(RTTNews) - Satsuma Pharmaceuticals Inc. (STSA) agreed to be acquired by Shin Nippon Biomedical Laboratories Ltd. for $0.91 in cash per share at the closing of the transaction plus one non ...